First study in decade provides hope for patients suffering from primary biliary cirrhosis

Mar 31, 2011

Results from an international study presented today at the International Liver Congress have shown Obeticholic Acid (OCA) is a safe and effective treatment in patients suffering from Primary Biliary Cirrhosis (PBC) as demonstrated by substantial decreases in the levels of alkaline phosphatase (AP) enzyme in the blood, a key marker for PBC.

In this double blind parallel group study, 59 patients received 10 or 50mg of OCA or a placebo once a day for 12 weeks. After 12 weeks the 10mg group showed the greatest reduction in AP levels.

PBC is a chronic disease that slowly destroys some of the tubes (bile ducts) linking the liver to the gut. PBC predominantly affects females at a ratio of approximately nine women to every one man. Bile ducts carry bile to the gut but in patients with PBC, bile can no longer flow through effectively and instead builds up in the liver, damaging the and causing inflammation and scarring. Long-term damage over the years can result in cirrhosis and .

Daniele Prati, EAS's Scientific Committee Member and Press Committee Chairman commented: "It is extremely encouraging to see that OCA seems to be effective in patients from a variety of countries. This is the first treatment trial in many years for patients with PBC that has shown such promising results. Further studies are needed to evaluate the action of this therapy compared to existing therapies and in larger patient populations."

OCA, 6-ethyl chenodeoxycholic acid (CDCA) or INT-747, is a novel derivative of CDCA, the natural ligand for the farnesoid-X receptor, a bile acid receptor which is found in the .

Explore further: ATS: Early prone positioning reduces mortality in ARDS

More information: References


1. Kowdley V.K et al. An International Study Evaluating the Farnesopid X Receptor Agonist Obeticholic Acid as Monotherapy in PBC. Presented at The International Liver Congress 2011

2. Primary Biliary Cirrhosis, British Liver Trust. www.britishlivertrust.org.uk/home/the-liver/liver-diseases/primary-biliary-cirrhosis.aspx . Accessed March 2011

3. What is Primary Biliary Cirrhosis, PBC Foundation – support for life. www.pbcfoundation.org.uk/Information.htm . Accessed March 2011

Provided by European Association for the Study of the Liver

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Toxic bile damages the liver

Oct 24, 2008

Researchers at the Heidelberg University Hospital have discovered a new genetic disease that can lead to severe liver damage. Because a protective component of the bile is missing, the liver cells are exposed to the toxic ...

Consortium finds chronic liver cirrhosis clues

Mar 13, 2011

Researchers have provided new clues into the genetics underlying a chronic form of liver disease, called primary biliary cirrhosis, which can lead to transplant surgery for patients. The new study identifies 15 genetic regions ...

Recommended for you

ATS: Early prone positioning reduces mortality in ARDS

16 minutes ago

(HealthDay)—For patients with acute respiratory distress syndrome (ARDS), prolonged prone positioning during mechanical ventilation is associated with significantly reduced mortality at 28 and 90 days, ...

No new H7N9 cases in China for a week

1 hour ago

No new human cases of the H7N9 virus have been recorded in China for a week, national health authorities said, for the first time since the outbreak began in March.

Report: NPS hantavirus response followed policy

12 hours ago

(AP)—Federal investigators probing the hantavirus outbreak blamed for three deaths at Yosemite National Park recommend that design changes to tent cabins and other lodging run by private concessionaires first be reviewed ...

New test better detects elephantiasis worm infection

13 hours ago

A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...

User comments : 0

More news stories

Holding drivers' attention

Each day, an average of nine people are killed in the United States and more than 1,000 injured by drivers doing something other than driving.

Biomarker trio predicts near-term heart risk

(Medical Xpress)—Cardiologists have identified a trio of biomarkers that may predict which patients with heart disease have a high risk of heart attack or death in the next two years.